PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease

article Editorial

Safety and Risk of Pharmacotherapy
Bezopasnostʹ i risk farmakoterapii

ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)

User

eng | рус

Safety and Risk of Pharmacotherapy

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease. Safety and Risk of Pharmacotherapy. 2023;11(4):473-474. (In Russ.) https://doi.org/10.30895/2312-7821-2023-11-4-473-474

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Safety and Risk of Pharmacotherapy

For citations:

Cookies policy